 |
PDS Biotech Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)PDS Biotechnology Corporation announced that the compensation committee of the board of directors of the Company approved, on September 13, 2021, an equity award to Gregory Reid, the Company’s new VP of Program Development, as a material inducement to Mr. Reid entering into employment with PDS Biotech. Research, News & Market Data on PDS Biotech |
 |
Esports Entertainment Group’s ggCircuit Partners with Square on Retail Integration SoftwareEsports Entertainment Group announced they have joined forces with world-leading point of sale and payment processing provider, Square (NYSE: SQ), to create ggLeap, a premium esports center management software Research, News & Market Data on EEG |
 |
Indonesia Energy Discovers Oil in Its Second Back-to-Back New Well at Kruh BlockIndonesia Energy announced that it has discovered oil in its “Kruh 26” well after having announced in July the discovery of oil in its Kruh 25 well Research, News & Market Data on Indonesia Energy |
 |
electroCore Announces New Patent Expanding Claims Related to Delivery of Non-Invasive Vagus Nerve Stimulation Therapy Using Mobile DeviceselectroCore announced that the United States Patent and Trademark Office has issued US Patent No. 11,097,102 to electroCore |
 |
Lifeist Wellness Announces Debut of New Ticker “LFST” on TSX Venture ExchangeLifeist Wellness announced that as part of its corporate name change and rebrand from “Namaste Technologies Inc.” to “Lifeist Wellness Inc.”, the Company’s common shares will continue to be publicly traded on the TSX Venture Exchange (the “TSXV”) under the new ticker symbol (“LFST”) |
 |
Data From Ongoing Clinical Trial Continues to Demonstrate a Single Administration of OpRegen® Can Provide Anatomical and Functional Improvements in Patients With Dry AMD With Geographic AtrophyLineage Cell Therapeutics announced updated interim results from its ongoing, 24-patient Phase 1/2a clinical study of its lead product candidate, OpRegen Research, News & Market Data on Lineage Cell Therapeutics |
 |
CanAlaska Options Key Extension Uranium ProjectCanAlaska Uranium announced it has entered into a Letter of Intent with Durama Enterprises Limited Research, News & Market Data on CanAlaska |
Stay up to date. Follow us:
|
